Syncorp Health announces a significant milestone on receiving approval on 20-07-2020,as a Start-up recognized by the Department of Industrial Policy and Promotion, Ministry of Commerce and Industry, Government of India.
Syncorp Health announces significant milestone - strategic tie up with Research Mentor South Korea to expand Clinical Research Services.
Syncorp Health worked with American Megatrends India (P) Ltd to clear the 510K substantial equivalence review by USFDA for BT4 (K182401).
Syncorp Health successfully supported the Sponsor in weight Management & Wound Healing product CT & obtained approvals from MFDS, South Korea.
Syncorp Health moved to a dedicated world class CRO facility at Bangalore.
In FY 18-20, Syncorp Health successfully conducted 30+ Medical Devices Clinical Validations.
In FY 18-20, Syncorp Health successfully conducted 20+ Nutraceutical and Ayurvedic Clinical Trials.